폐암 치료의 최신 지견, 폐선암을 중심으로

Title
폐암 치료의 최신 지견, 폐선암을 중심으로
Other Titles
Update on Lung Cancer Treatment Focused on Adenocarcinoma
Authors
최원일
Keimyung Author(s)
최원일
Department
Dept. of Internal Medicine (내과학)
Keywords
Adenocarcinoma; Nonsmall cell lung cancer; Targeted therapy
Issue Date
2012
Publisher
Keimyung University School of Medicine
Citation
Keimyung Medical Journal, Vol.31(1) : 36-44, 2012
Abstract
Last 20 years, great progress has been made in the care of advanced non-small cell lung cancer, especially adenocarcinoma. One year survival of advanced non-small cell lung cancer increases from 30% to 55%. Third-generation regimens with or without front-line targeted agents, or with efficient second- and third line low toxicity therapies may contribute improving survival. The emergence of targeted therapy in first- and second-line settings has spectacularly changed the natural history of disease especially EGFR mutated cancer, leading to dramatically prolonged overall survival. Maintenance therapy, either with targeted agents or cytotoxic agents, also improved survival for larger groups of non-small cell lung cancer.
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/15552
Appears in Collections:
2. Keimyung Medical Journal (계명의대 학술지) > 2012
1. 연구논문 > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Files in This Item:
31-36.pdf(600.3 kB)Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE